Pharmacotherapeutic Considerations for Using Colchicine to Treat Idiopathic Pericarditis in the USA
Time to Reconsider Dabigatran 110 mg in the USA
Risks and Benefits of Low Molecular-Weight Heparin and Target-Specific Oral Anticoagulant Use for Thromboprophylaxis in Medically Ill Patients
Non-Vitamin K Antagonist Oral Anticoagulants: New Choices for Patient Management in Atrial Fibrillation
One-Year Post-Discharge Resource Utilization and Treatment Patterns of Patients with Acute Coronary Syndrome Managed with Percutaneous Coronary Intervention and Treated with Ticagrelor or Prasugrel
Edoxaban: A Review in Nonvalvular Atrial Fibrillation
Perindopril/Amlodipine (Prestalia®): A Review in Hypertension
Comment on: “Pharmacokinetics and Tolerability of the Novel Oral Prostacyclin IP Receptor Agonist Selexipag”
Authors' Reply to Srinivas: “Pharmacokinetics and Tolerability of the Novel Oral Prostacyclin IP Receptor Agonist Selexipag”